- Home
- BTAI vs LSH Comparison
BTAI vs LSH Comparison
Compare BTAI & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- LSH
- Stock Information
- Founded
- BTAI 2017
- LSH 2018
- Country
- BTAI United States
- LSH United States
- Employees
- BTAI N/A
- LSH N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- LSH
- Sector
- BTAI Health Care
- LSH
- Exchange
- BTAI Nasdaq
- LSH NYSE
- Market Cap
- BTAI 8.3M
- LSH 9.4M
- IPO Year
- BTAI 2018
- LSH 2024
- Fundamental
- Price
- BTAI $1.81
- LSH $0.84
- Analyst Decision
- BTAI Buy
- LSH
- Analyst Count
- BTAI 5
- LSH 0
- Target Price
- BTAI $34.80
- LSH N/A
- AVG Volume (30 Days)
- BTAI 325.6K
- LSH 14.4K
- Earning Date
- BTAI 08-05-2025
- LSH 08-05-2025
- Dividend Yield
- BTAI N/A
- LSH N/A
- EPS Growth
- BTAI N/A
- LSH N/A
- EPS
- BTAI N/A
- LSH N/A
- Revenue
- BTAI $1,852,000.00
- LSH $16,270,095.00
- Revenue This Year
- BTAI N/A
- LSH N/A
- Revenue Next Year
- BTAI $362.49
- LSH N/A
- P/E Ratio
- BTAI N/A
- LSH N/A
- Revenue Growth
- BTAI 5.47
- LSH N/A
- 52 Week Low
- BTAI $1.17
- LSH $0.82
- 52 Week High
- BTAI $19.84
- LSH $4.34
- Technical
- Relative Strength Index (RSI)
- BTAI 48.12
- LSH N/A
- Support Level
- BTAI $1.70
- LSH N/A
- Resistance Level
- BTAI $2.00
- LSH N/A
- Average True Range (ATR)
- BTAI 0.15
- LSH 0.00
- MACD
- BTAI -0.03
- LSH 0.00
- Stochastic Oscillator
- BTAI 20.00
- LSH 0.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About LSH LAKESIDE HOLDING LTD
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.